0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Novel Drug Delivery Systems Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-30X82
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Novel Drug Delivery Systems Market Size Status and Forecast 2022
BUY CHAPTERS

Global Novel Drug Delivery Systems Market Research Report 2024

Code: QYRE-Auto-30X82
Report
January 2024
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Novel Drug Delivery Systems Market Size

The global Novel Drug Delivery Systems market was valued at US$ 24300 million in 2023 and is anticipated to reach US$ 27380 million by 2030, witnessing a CAGR of 1.7% during the forecast period 2024-2030.

Novel Drug Delivery Systems Market

Novel Drug Delivery Systems Market

Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
Global Novel Drug Delivery Systems key players include Amgen, Teva, Roche, UCB (Union Chimique Belge), etc. Global top four manufacturers hold a share over 40%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%. And in terms of application, the largest application is Hospitals & Clinic, followed by Cancer Treatment Centers, etc.
This report aims to provide a comprehensive presentation of the global market for Novel Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Novel Drug Delivery Systems.

Report Scope

The Novel Drug Delivery Systems market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Novel Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Novel Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Novel Drug Delivery Systems Market Report

Report Metric Details
Report Name Novel Drug Delivery Systems Market
Accounted market size in 2023 US$ 24300 million
Forecasted market size in 2030 US$ 27380 million
CAGR 1.7%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Liposomes
  • PEGylated Proteins & Polypeptides
  • Polymer Nanoparticle
  • Protein–drug Conjugates
  • Others
Segment by Application
  • Hospitals & Clinic
  • Cancer Treatment Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, Bausch&Lomb, Samyang Biopharmaceuticals, Johnson & Johnson, TOLMAR, Astellas, AMAG Pharmaceuticals, AbbVie, Dr Reddy, AstraZeneca, Aspen, Acrotech Biopharma, TWi Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Novel Drug Delivery Systems companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Novel Drug Delivery Systems Market growing?

Ans: The Novel Drug Delivery Systems Market witnessing a CAGR of 1.7% during the forecast period 2024-2030.

What is the Novel Drug Delivery Systems Market size in 2030?

Ans: The Novel Drug Delivery Systems Market size in 2030 will be US$ 27380 million.

What is the market share of major companies in Novel Drug Delivery Systems Market?

Ans: Global top four manufacturers hold a share over 40%.

What is the Novel Drug Delivery Systems Market share by type?

Ans: In terms of product, PEGylated Proteins & Polypeptides is the largest segment, with a share about 40%.

Who are the main players in the Novel Drug Delivery Systems Market report?

Ans: The main players in the Novel Drug Delivery Systems Market are Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, Bausch&Lomb, Samyang Biopharmaceuticals, Johnson & Johnson, TOLMAR, Astellas, AMAG Pharmaceuticals, AbbVie, Dr Reddy, AstraZeneca, Aspen, Acrotech Biopharma, TWi Pharmaceuticals

What are the Application segmentation covered in the Novel Drug Delivery Systems Market report?

Ans: The Applications covered in the Novel Drug Delivery Systems Market report are Hospitals & Clinic, Cancer Treatment Centers, Others

What are the Type segmentation covered in the Novel Drug Delivery Systems Market report?

Ans: The Types covered in the Novel Drug Delivery Systems Market report are Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Drug Delivery Systems Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liposomes
1.2.3 PEGylated Proteins & Polypeptides
1.2.4 Polymer Nanoparticle
1.2.5 Protein–drug Conjugates
1.2.6 Others
1.3 Market by Application
1.3.1 Global Novel Drug Delivery Systems Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Novel Drug Delivery Systems Market Perspective (2019-2030)
2.2 Novel Drug Delivery Systems Growth Trends by Region
2.2.1 Global Novel Drug Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Novel Drug Delivery Systems Historic Market Size by Region (2019-2024)
2.2.3 Novel Drug Delivery Systems Forecasted Market Size by Region (2025-2030)
2.3 Novel Drug Delivery Systems Market Dynamics
2.3.1 Novel Drug Delivery Systems Industry Trends
2.3.2 Novel Drug Delivery Systems Market Drivers
2.3.3 Novel Drug Delivery Systems Market Challenges
2.3.4 Novel Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Novel Drug Delivery Systems Players by Revenue
3.1.1 Global Top Novel Drug Delivery Systems Players by Revenue (2019-2024)
3.1.2 Global Novel Drug Delivery Systems Revenue Market Share by Players (2019-2024)
3.2 Global Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Novel Drug Delivery Systems Revenue
3.4 Global Novel Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Novel Drug Delivery Systems Revenue in 2023
3.5 Novel Drug Delivery Systems Key Players Head office and Area Served
3.6 Key Players Novel Drug Delivery Systems Product Solution and Service
3.7 Date of Enter into Novel Drug Delivery Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Drug Delivery Systems Breakdown Data by Type
4.1 Global Novel Drug Delivery Systems Historic Market Size by Type (2019-2024)
4.2 Global Novel Drug Delivery Systems Forecasted Market Size by Type (2025-2030)
5 Novel Drug Delivery Systems Breakdown Data by Application
5.1 Global Novel Drug Delivery Systems Historic Market Size by Application (2019-2024)
5.2 Global Novel Drug Delivery Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Novel Drug Delivery Systems Market Size (2019-2030)
6.2 North America Novel Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Novel Drug Delivery Systems Market Size by Country (2019-2024)
6.4 North America Novel Drug Delivery Systems Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Novel Drug Delivery Systems Market Size (2019-2030)
7.2 Europe Novel Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Novel Drug Delivery Systems Market Size by Country (2019-2024)
7.4 Europe Novel Drug Delivery Systems Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Novel Drug Delivery Systems Market Size (2019-2030)
8.2 Asia-Pacific Novel Drug Delivery Systems Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2019-2024)
8.4 Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Novel Drug Delivery Systems Market Size (2019-2030)
9.2 Latin America Novel Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Novel Drug Delivery Systems Market Size by Country (2019-2024)
9.4 Latin America Novel Drug Delivery Systems Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Novel Drug Delivery Systems Market Size (2019-2030)
10.2 Middle East & Africa Novel Drug Delivery Systems Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2019-2024)
10.4 Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Novel Drug Delivery Systems Introduction
11.1.4 Amgen Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.1.5 Amgen Recent Development
11.2 Teva
11.2.1 Teva Company Detail
11.2.2 Teva Business Overview
11.2.3 Teva Novel Drug Delivery Systems Introduction
11.2.4 Teva Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.2.5 Teva Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Novel Drug Delivery Systems Introduction
11.3.4 Roche Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.3.5 Roche Recent Development
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Detail
11.4.2 UCB (Union Chimique Belge) Business Overview
11.4.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Introduction
11.4.4 UCB (Union Chimique Belge) Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.4.5 UCB (Union Chimique Belge) Recent Development
11.5 Celgene
11.5.1 Celgene Company Detail
11.5.2 Celgene Business Overview
11.5.3 Celgene Novel Drug Delivery Systems Introduction
11.5.4 Celgene Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.5.5 Celgene Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Novel Drug Delivery Systems Introduction
11.6.4 Merck Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Detail
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Novel Drug Delivery Systems Introduction
11.7.4 Gilead Sciences Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.7.5 Gilead Sciences Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Novel Drug Delivery Systems Introduction
11.8.4 Sanofi Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.8.5 Sanofi Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Novel Drug Delivery Systems Introduction
11.9.4 Pfizer Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Novel Drug Delivery Systems Introduction
11.10.4 Takeda Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.10.5 Takeda Recent Development
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Detail
11.11.2 Bausch&Lomb Business Overview
11.11.3 Bausch&Lomb Novel Drug Delivery Systems Introduction
11.11.4 Bausch&Lomb Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.11.5 Bausch&Lomb Recent Development
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Detail
11.12.2 Samyang Biopharmaceuticals Business Overview
11.12.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Introduction
11.12.4 Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.12.5 Samyang Biopharmaceuticals Recent Development
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Detail
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Novel Drug Delivery Systems Introduction
11.13.4 Johnson & Johnson Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.13.5 Johnson & Johnson Recent Development
11.14 TOLMAR
11.14.1 TOLMAR Company Detail
11.14.2 TOLMAR Business Overview
11.14.3 TOLMAR Novel Drug Delivery Systems Introduction
11.14.4 TOLMAR Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.14.5 TOLMAR Recent Development
11.15 Astellas
11.15.1 Astellas Company Detail
11.15.2 Astellas Business Overview
11.15.3 Astellas Novel Drug Delivery Systems Introduction
11.15.4 Astellas Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.15.5 Astellas Recent Development
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Detail
11.16.2 AMAG Pharmaceuticals Business Overview
11.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Introduction
11.16.4 AMAG Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.16.5 AMAG Pharmaceuticals Recent Development
11.17 AbbVie
11.17.1 AbbVie Company Detail
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Novel Drug Delivery Systems Introduction
11.17.4 AbbVie Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.17.5 AbbVie Recent Development
11.18 Dr Reddy
11.18.1 Dr Reddy Company Detail
11.18.2 Dr Reddy Business Overview
11.18.3 Dr Reddy Novel Drug Delivery Systems Introduction
11.18.4 Dr Reddy Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.18.5 Dr Reddy Recent Development
11.19 AstraZeneca
11.19.1 AstraZeneca Company Detail
11.19.2 AstraZeneca Business Overview
11.19.3 AstraZeneca Novel Drug Delivery Systems Introduction
11.19.4 AstraZeneca Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.19.5 AstraZeneca Recent Development
11.20 Aspen
11.20.1 Aspen Company Detail
11.20.2 Aspen Business Overview
11.20.3 Aspen Novel Drug Delivery Systems Introduction
11.20.4 Aspen Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.20.5 Aspen Recent Development
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Detail
11.21.2 Acrotech Biopharma Business Overview
11.21.3 Acrotech Biopharma Novel Drug Delivery Systems Introduction
11.21.4 Acrotech Biopharma Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.21.5 Acrotech Biopharma Recent Development
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Detail
11.22.2 TWi Pharmaceuticals Business Overview
11.22.3 TWi Pharmaceuticals Novel Drug Delivery Systems Introduction
11.22.4 TWi Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2019-2024)
11.22.5 TWi Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Novel Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Liposomes
    Table 3. Key Players of PEGylated Proteins & Polypeptides
    Table 4. Key Players of Polymer Nanoparticle
    Table 5. Key Players of Protein–drug Conjugates
    Table 6. Key Players of Others
    Table 7. Global Novel Drug Delivery Systems Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Novel Drug Delivery Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Novel Drug Delivery Systems Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Novel Drug Delivery Systems Market Share by Region (2019-2024)
    Table 11. Global Novel Drug Delivery Systems Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Novel Drug Delivery Systems Market Share by Region (2025-2030)
    Table 13. Novel Drug Delivery Systems Market Trends
    Table 14. Novel Drug Delivery Systems Market Drivers
    Table 15. Novel Drug Delivery Systems Market Challenges
    Table 16. Novel Drug Delivery Systems Market Restraints
    Table 17. Global Novel Drug Delivery Systems Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Novel Drug Delivery Systems Market Share by Players (2019-2024)
    Table 19. Global Top Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems as of 2023)
    Table 20. Ranking of Global Top Novel Drug Delivery Systems Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Novel Drug Delivery Systems Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Novel Drug Delivery Systems Product Solution and Service
    Table 24. Date of Enter into Novel Drug Delivery Systems Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Novel Drug Delivery Systems Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Novel Drug Delivery Systems Revenue Market Share by Type (2019-2024)
    Table 28. Global Novel Drug Delivery Systems Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Novel Drug Delivery Systems Revenue Market Share by Type (2025-2030)
    Table 30. Global Novel Drug Delivery Systems Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Novel Drug Delivery Systems Revenue Market Share by Application (2019-2024)
    Table 32. Global Novel Drug Delivery Systems Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Novel Drug Delivery Systems Revenue Market Share by Application (2025-2030)
    Table 34. North America Novel Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Novel Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Novel Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Novel Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Novel Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Novel Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Novel Drug Delivery Systems Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Novel Drug Delivery Systems Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Novel Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Novel Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Novel Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Novel Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Novel Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Amgen Company Detail
    Table 50. Amgen Business Overview
    Table 51. Amgen Novel Drug Delivery Systems Product
    Table 52. Amgen Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 53. Amgen Recent Development
    Table 54. Teva Company Detail
    Table 55. Teva Business Overview
    Table 56. Teva Novel Drug Delivery Systems Product
    Table 57. Teva Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 58. Teva Recent Development
    Table 59. Roche Company Detail
    Table 60. Roche Business Overview
    Table 61. Roche Novel Drug Delivery Systems Product
    Table 62. Roche Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 63. Roche Recent Development
    Table 64. UCB (Union Chimique Belge) Company Detail
    Table 65. UCB (Union Chimique Belge) Business Overview
    Table 66. UCB (Union Chimique Belge) Novel Drug Delivery Systems Product
    Table 67. UCB (Union Chimique Belge) Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 68. UCB (Union Chimique Belge) Recent Development
    Table 69. Celgene Company Detail
    Table 70. Celgene Business Overview
    Table 71. Celgene Novel Drug Delivery Systems Product
    Table 72. Celgene Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 73. Celgene Recent Development
    Table 74. Merck Company Detail
    Table 75. Merck Business Overview
    Table 76. Merck Novel Drug Delivery Systems Product
    Table 77. Merck Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 78. Merck Recent Development
    Table 79. Gilead Sciences Company Detail
    Table 80. Gilead Sciences Business Overview
    Table 81. Gilead Sciences Novel Drug Delivery Systems Product
    Table 82. Gilead Sciences Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 83. Gilead Sciences Recent Development
    Table 84. Sanofi Company Detail
    Table 85. Sanofi Business Overview
    Table 86. Sanofi Novel Drug Delivery Systems Product
    Table 87. Sanofi Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 88. Sanofi Recent Development
    Table 89. Pfizer Company Detail
    Table 90. Pfizer Business Overview
    Table 91. Pfizer Novel Drug Delivery Systems Product
    Table 92. Pfizer Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 93. Pfizer Recent Development
    Table 94. Takeda Company Detail
    Table 95. Takeda Business Overview
    Table 96. Takeda Novel Drug Delivery Systems Product
    Table 97. Takeda Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 98. Takeda Recent Development
    Table 99. Bausch&Lomb Company Detail
    Table 100. Bausch&Lomb Business Overview
    Table 101. Bausch&Lomb Novel Drug Delivery Systems Product
    Table 102. Bausch&Lomb Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 103. Bausch&Lomb Recent Development
    Table 104. Samyang Biopharmaceuticals Company Detail
    Table 105. Samyang Biopharmaceuticals Business Overview
    Table 106. Samyang Biopharmaceuticals Novel Drug Delivery Systems Product
    Table 107. Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 108. Samyang Biopharmaceuticals Recent Development
    Table 109. Johnson & Johnson Company Detail
    Table 110. Johnson & Johnson Business Overview
    Table 111. Johnson & Johnson Novel Drug Delivery Systems Product
    Table 112. Johnson & Johnson Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 113. Johnson & Johnson Recent Development
    Table 114. TOLMAR Company Detail
    Table 115. TOLMAR Business Overview
    Table 116. TOLMAR Novel Drug Delivery Systems Product
    Table 117. TOLMAR Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 118. TOLMAR Recent Development
    Table 119. Astellas Company Detail
    Table 120. Astellas Business Overview
    Table 121. Astellas Novel Drug Delivery Systems Product
    Table 122. Astellas Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 123. Astellas Recent Development
    Table 124. AMAG Pharmaceuticals Company Detail
    Table 125. AMAG Pharmaceuticals Business Overview
    Table 126. AMAG Pharmaceuticals Novel Drug Delivery Systems Product
    Table 127. AMAG Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 128. AMAG Pharmaceuticals Recent Development
    Table 129. AbbVie Company Detail
    Table 130. AbbVie Business Overview
    Table 131. AbbVie Novel Drug Delivery Systems Product
    Table 132. AbbVie Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 133. AbbVie Recent Development
    Table 134. Dr Reddy Company Detail
    Table 135. Dr Reddy Business Overview
    Table 136. Dr Reddy Novel Drug Delivery Systems Product
    Table 137. Dr Reddy Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 138. Dr Reddy Recent Development
    Table 139. AstraZeneca Company Detail
    Table 140. AstraZeneca Business Overview
    Table 141. AstraZeneca Novel Drug Delivery Systems Product
    Table 142. AstraZeneca Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 143. AstraZeneca Recent Development
    Table 144. Aspen Company Detail
    Table 145. Aspen Business Overview
    Table 146. Aspen Novel Drug Delivery Systems Product
    Table 147. Aspen Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 148. Aspen Recent Development
    Table 149. Acrotech Biopharma Company Detail
    Table 150. Acrotech Biopharma Business Overview
    Table 151. Acrotech Biopharma Novel Drug Delivery Systems Product
    Table 152. Acrotech Biopharma Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 153. Acrotech Biopharma Recent Development
    Table 154. TWi Pharmaceuticals Company Detail
    Table 155. TWi Pharmaceuticals Business Overview
    Table 156. TWi Pharmaceuticals Novel Drug Delivery Systems Product
    Table 157. TWi Pharmaceuticals Revenue in Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 158. TWi Pharmaceuticals Recent Development
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Novel Drug Delivery Systems Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Novel Drug Delivery Systems Market Share by Type: 2023 VS 2030
    Figure 3. Liposomes Features
    Figure 4. PEGylated Proteins & Polypeptides Features
    Figure 5. Polymer Nanoparticle Features
    Figure 6. Protein–drug Conjugates Features
    Figure 7. Others Features
    Figure 8. Global Novel Drug Delivery Systems Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Novel Drug Delivery Systems Market Share by Application: 2023 VS 2030
    Figure 10. Hospitals & Clinic Case Studies
    Figure 11. Cancer Treatment Centers Case Studies
    Figure 12. Others Case Studies
    Figure 13. Novel Drug Delivery Systems Report Years Considered
    Figure 14. Global Novel Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Novel Drug Delivery Systems Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Novel Drug Delivery Systems Market Share by Region: 2023 VS 2030
    Figure 17. Global Novel Drug Delivery Systems Market Share by Players in 2023
    Figure 18. Global Top Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Drug Delivery Systems as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Novel Drug Delivery Systems Revenue in 2023
    Figure 20. North America Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Novel Drug Delivery Systems Market Share by Country (2019-2030)
    Figure 22. United States Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Novel Drug Delivery Systems Market Share by Country (2019-2030)
    Figure 26. Germany Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Novel Drug Delivery Systems Market Share by Region (2019-2030)
    Figure 34. China Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Novel Drug Delivery Systems Market Share by Country (2019-2030)
    Figure 42. Mexico Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Novel Drug Delivery Systems Market Share by Country (2019-2030)
    Figure 46. Turkey Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Amgen Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 49. Teva Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 50. Roche Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 51. UCB (Union Chimique Belge) Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 52. Celgene Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 53. Merck Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 54. Gilead Sciences Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 55. Sanofi Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 56. Pfizer Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 57. Takeda Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 58. Bausch&Lomb Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 59. Samyang Biopharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 60. Johnson & Johnson Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 61. TOLMAR Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 62. Astellas Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 63. AMAG Pharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 64. AbbVie Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 65. Dr Reddy Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 66. AstraZeneca Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 67. Aspen Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 68. Acrotech Biopharma Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 69. TWi Pharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS